Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models

por Déruaz, Maud, Bonvin, Pauline, Severin, India C, Johnson, Zoë, Krohn, Sonja, Power, Christine A, Proudfoot, Amanda E I
Publicado 2013

Glycosaminoglycan analogs as a novel anti-inflammatory strategy

por Severin, India C., Soares, Adriano, Hantson, Jennifer, Teixeira, Mauro, Sachs, Daniela, Valognes, Delphine, Scheer, Alexander, Schwarz, Matthias K., Wells, Timothy N. C., Proudfoot, Amanda E. I., Shaw, Jeffrey
Publicado 2012